INDEX.ST Stock Chart

InDex Pharmaceuticals Holding is a company that focuses on immunological diseases. It develops cobitolimod, a medication for patients with moderate-to-severe active ulcerative colitis. In addition, the company provides a platform for patent protected discovery stage substances, which can be used in treatment of various immunological diseases.